Article: Drugs Intended for The Treatment of Epilepsy and Schizophrenia Are Often Used for Other Diseases; Off-label Use of Central Nervous System Drugs Can Account for 25% to More Than 80% of a Drug's Total Sales, According to a New Report from Decision Resources.

WALTHAM, Mass. -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced today that drugs intended for the treatment of epilepsy and schizophrenia are often used for other diseases. Off-label use of central nervous system drugs can account for 25% to more than 80% of a drug's total sales, according to a new PhysicianForum report from Decision Resources entitled Off-Label Use of CNS Drugs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION )

"For many central nervous system indications, off-label prescribing is quite significant. For example, the antiepileptic drugs ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!